About this trial
Bronchial fibroscopy (BF) is a routine practice examination in critical care areas. It can be useful either for the diagnosis of the causal pathology of respiratory distress or for the diagnosis of lung infection, sometimes nosocomial. In patients in spontaneous and conscious ventilation, BF are performed vigil after local anesthesia according to the recommendations of the Société de Pneumologie de langue Française. The good tolerance of the examination and its good conduct may require the use of anxiolytics, sedatives or analgesics to limit the traumatic experience of a highly anxiety-provoking examination. Virtual reality (VR) combines a set of paramedical techniques (hypnosis, music therapy, sophrology) and is now a non-drug alternative to improve the tolerance of certain invasive gestures.VR has been shown to reduce pain and anxiety during first pathways placement or digestive endoscopies. To date, there is no evidence of the benefit of VR when performing semi-urgent BF in critical care areas.
Eligibility criteria
Qualifiers
Adults (over 18 years of age)
Hospitalized in a critical care unit (intensive care and intensive care)
Conscious (Glasgow score >13)
Spontaneous ventilation
Disqualifiers
Non-French-speaking patient
Protected minors or adults who cannot consent to participate
People with major neurocognitive impairment
Patient refusing to participate in the study
Trial design
Treatments tested in this trial
- Virtual reality headset
Treatment groups
Sponsors and collaborators
Assistance Publique - Hôpitaux de Paris
Lead sponsor
Ministry of Health, France
Collaborator